Finadyne 50 mg/g Oral Paste

Země: Velká Británie

Jazyk: angličtina

Zdroj: VMD (Veterinary Medicines Directorate)

Aktivní složka:

Flunixin

Dostupné s:

MSD Animal Health UK Limited

ATC kód:

QM01AG90

INN (Mezinárodní Name):

Flunixin

Léková forma:

Oral paste

Druh předpisu:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutické skupiny:

Horses

Terapeutické oblasti:

Anti Inflammatory NSAID

Stav Autorizace:

Authorized

Datum autorizace:

1989-02-02

Charakteristika produktu

Revised: October 2022
AN: 01265/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Finadyne 50 mg/g Oral Paste
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each gram contains:
ACTIVE SUBSTANCE:
Flunixin 50 mg as flunixin meglumine 83 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Oral paste.
White to off-white paste.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the alleviation of inflammation and pain associated with
musculoskeletal disorders
in the horse.
4.3
CONTRAINDICATIONS
Do not exceed the stated dose or duration of treatment.
Do not use in animals suffering from cardiac, hepatic or renal
disease, or where there
is the possibility of gastrointestinal ulceration or bleeding.
Do not use in cases of hypersensitivity to the active substance.
Do not administer steroidal or other non-steroidal anti-inflammatory
drugs
concurrently or within 24 hours of each other.
Do not use in hypovolaemic animals except in the case of endotoxaemia
or septic
shock.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Non-steroidal anti-inflammatory drugs are not permitted substances
under the rules of
racing and under rules covering other competitive events. The Royal
College of
Revised: October 2022
AN: 01265/2022
Page 2 of 5
Veterinary Surgeons has given guidance to the Veterinary profession
regarding the
use of anti-inflammatory drugs in competing horses. It states that if
a veterinarian
recommends the discontinuation of any such drug not less than eight
days before
racing he should feel sure he has catered for all but the most
exceptional case.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals:
Use in animals less than 6 weeks of age or in aged animals may involve
additional
risk.
If such use cannot be avoided animals may require a reduced dosage and
careful
clinical management.
In animals undergoing general anaesthesia it is preferable to wait
until they are fully
r